Bontia Bio uses synthetic biology to produce potent, naturally derived bioactive compounds through microbial fermentation. Their Fungal Factories™ platform enables the creation of sustainable, low-toxicity solutions for animal health and agriculture, starting with non-toxic pest control for companion animals.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional animal health and agricultural solutions often rely on synthetic chemicals, posing environmental concerns and potential toxicity risks. The development of effective, sustainable alternatives for pest control and animal well-being is a significant challenge.
Solution
Bontia Bio utilizes a proprietary synthetic biology platform, Fungal Factories™, to reconstruct natural biosynthetic pathways. This process enables the microbial production of potent bioactive compounds through fermentation, minimizing the need for synthetic chemical inputs. The company's approach leverages nature's existing biological mechanisms to create sustainable solutions for animal health and agriculture. Their initial product targets invertebrate pests with a focus on non-toxic, eco-friendly formulations.
Target Audience
Bontia Bio targets the animal health and agricultural sectors, specifically focusing on companion animal owners and producers seeking sustainable pest control solutions.
Features
- Proprietary Fungal Factories™ synthetic biology platform for microbial production of bioactive compounds.
- Reconstruction of natural biosynthetic pathways to generate compounds via fermentation.
- Focus on producing potent, naturally derived compounds with minimal synthetic chemical use.
- Development of orally delivered animal health medications targeting invertebrate pests.
- Formulations designed for low mammalian toxicity and environmental sustainability.